Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Most Doctors Say FDA Should Continue To Restrict Off-Label Drug Marketing: Study January 29, 2019 Irvin Jackson Add Your Comments A recent survey suggests that most doctors still want federal regulators to strictly enforce marketing limitations on drug companies, to prevent them from promoting their medications for “off-label” uses that have never been approved as safe and effective. In a research letter presented last week in the medical journal JAMA Internal Medicine, researchers from Harvard, Dartmouth’s Center for Medicine and the Media, and the American Board of Internal Medicine published the results of a survey of 686 respondents, including internists, endocrinologists, and cardiologists who were asked about off-label drug promotion, as well as FDA approval standards and drug-evaluation and pricing. The findings come as the FDA has been seen as quietly stepping back from aggressive enforcement of so-called “off-label marketing” restrictions following a number of court losses, which may open the door for pharmaceutical companies to push for expanded sales by encouraging use of their drugs for indications that have not been sufficiently supported through research and testing. Do You Know about… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Do You Know About… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Although doctors are free to prescribe any approved medication for any use they see fit, which is commonly referred to as “off-label” prescribing, manufacturers are only allowed to promote uses that have been approved by the FDA. Any marketing that appears promote the drug for an unapproved use, could get the drug labeled as misbranded or adulterated, and could result in the company being cited for false and misleading advertising. Manufacturers have been pushing back on these rules for years, arguing that freedom of speech should allow their representatives to communicate with doctors about studies and other data that suggest that drugs may be effective for non-approved uses, even when they have not yet received found the data sufficiently reliable to expand the indicated uses. The drug companies have argued that as long as the information is accurately presented, they should not run afoul of the agency’s rules. According to the findings of this new survey, 60 percent of respondents said the FDA should “definitely not” or “probably not” allow drug companies to promote their medications to doctors off-label. In addition, about 70 percent thought it was a bad or terrible idea to allow sales representatives to make such promotions in doctors’ offices, or allow them to publish such promotions in medical journals. Most of the doctors rejected drug industry claims that such promotions and data would be beneficial, the researchers found. “Many predicted that off-label promotion would increase prescriptions for drugs without meaningful benefits and for diseases not previously considered medical problems,” the researchers report. “Physicians were much more likely to believe that off-label promotion would worsen (rather than improve) clinical decisions.” A study published in 2015 in the same medical journal found that off-label use of drugs places patients at a 44 percent increased risk of suffering an adverse drug event. FDA Retreating From Off-Label Marketing Enforcement A Forbes article in late November 2018 warned that the FDA is quietly backing away from stringent enforcement of off-label promotion restrictions in some cases after the FDA’s Director of the Center for Drug Evaluation and Research, Janet Woodcock, told a conference that the agency was content with letting the industry police itself in the form of competitors filing lawsuits against other drug companies when they had pushed off-label promotions too far. The change is a significant turnaround for an agency which had been heavily cracking down on off-label promotion violations under the Obama administration. In November 2013, Johnson & Johnson agreed to pay $2.2 billion to the federal government to settle its Risperdal illegal marketing claims. Investigators say that the illegal marketing led to the unnecessary and risky use of drugs like Risperdal, which is sometimes used in nursing homes as a form of chemical restraint, potentially putting dementia patients’ lives at risk. Off-label marketing of the anti-nausea drug Zofran also led to a $3 billion settlement by GlaxoSmithKline, after the federal government pointed out that it was promoting the drug for pregnancy-related morning sickness, even though the drug maker never conducted any studies to establish that Zofran use was safe for unborn children during pregnancy. However, in 2012 the 2nd U.S. Circuit Court of Appeals ruled that off-label marketing is protected commercial free speech if the company’s information is truthful and accurate in U.S. v. Caronia, overturning a verdict against a pharmaceutical sales representative. The U.S. government declined to push the case to the Supreme Court, leaving enforcement of off-label marketing restrictions uncertain. The FDA issued updated guidance (PDF) on presenting scientific data on off-label drug uses in June 2018. Tags: False Advertising, Off-Label Marketing More Lawsuit Stories Over 550 Depo-Provera Lawsuits Being Pursued by Women With Meningioma Brain Tumors July 15, 2025 Judge Rejects Uber’s Attempt To Dismiss All Driver Sex Assault Bellwether Lawsuits July 15, 2025 Nursing Home Staffing Problems Worsening Amid Immigration Crackdowns: AP Report July 15, 2025 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermPhoneThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Over 550 Depo-Provera Lawsuits Being Pursued by Women With Meningioma Brain Tumors (Posted: today) As the Depo-Provera MDL moves toward its first jury trials, the litigation has reached a key milestone, with more than 550 lawsuits filed over brain tumor injuries linked to the birth control injection. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Shots Triple Brain Tumor Risks Compared to Birth Control Pill: Study (07/11/2025)Depo-Provera Lawsuit Pre-Settlement Funding and Loans Must Be Disclosed Under Court Order (07/09/2025)Depo-Provera Wrongful Death Lawsuit Blames Injections for Fatal Brain Tumor (07/02/2025) Suboxone Injury Lawyers Reappointed to Leadership Roles in Federal MDL (Posted: yesterday) A federal judge has confirmed the reappointment of more than two dozen Suboxone injury lawyers to serve in leadership positions representing plaintiffs for another year. MORE ABOUT: SUBOXONE TOOTH DECAY LAWSUITGas Station Heroin Class Action Lawsuit Filed Over Addictive Properties of ZaZa Supplements (07/03/2025)Lawyers To Select 50 Suboxone Dental Lawsuits for Next Phase of MDL Bellwether Discovery (05/22/2025)500 Suboxone Tooth Decay Cases Randomly Selected for Bellwether Record Collection Pool (04/24/2025) Uber Faces Lawsuit Indicating Driver Raped Passenger After Using Wife’s Account (Posted: 5 days ago) A lawsuit filed by a Florida woman says she was raped after an Uber driver’s husband showed up behind the wheel. MORE ABOUT: UBER SEXUAL ASSAULT LAWSUITJudge Rejects Uber’s Attempt To Dismiss All Driver Sex Assault Bellwether Lawsuits (07/15/2025)Uber Driver Background Check Materials Must Be Produced in Sexual Assault Lawsuits: Court (06/17/2025)MDL Judge Updated on Uber Driver Sex Assault Lawsuit Status as Claims Top 2,800 (06/06/2025)
Over 550 Depo-Provera Lawsuits Being Pursued by Women With Meningioma Brain Tumors (Posted: today) As the Depo-Provera MDL moves toward its first jury trials, the litigation has reached a key milestone, with more than 550 lawsuits filed over brain tumor injuries linked to the birth control injection. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Shots Triple Brain Tumor Risks Compared to Birth Control Pill: Study (07/11/2025)Depo-Provera Lawsuit Pre-Settlement Funding and Loans Must Be Disclosed Under Court Order (07/09/2025)Depo-Provera Wrongful Death Lawsuit Blames Injections for Fatal Brain Tumor (07/02/2025)
Suboxone Injury Lawyers Reappointed to Leadership Roles in Federal MDL (Posted: yesterday) A federal judge has confirmed the reappointment of more than two dozen Suboxone injury lawyers to serve in leadership positions representing plaintiffs for another year. MORE ABOUT: SUBOXONE TOOTH DECAY LAWSUITGas Station Heroin Class Action Lawsuit Filed Over Addictive Properties of ZaZa Supplements (07/03/2025)Lawyers To Select 50 Suboxone Dental Lawsuits for Next Phase of MDL Bellwether Discovery (05/22/2025)500 Suboxone Tooth Decay Cases Randomly Selected for Bellwether Record Collection Pool (04/24/2025)
Uber Faces Lawsuit Indicating Driver Raped Passenger After Using Wife’s Account (Posted: 5 days ago) A lawsuit filed by a Florida woman says she was raped after an Uber driver’s husband showed up behind the wheel. MORE ABOUT: UBER SEXUAL ASSAULT LAWSUITJudge Rejects Uber’s Attempt To Dismiss All Driver Sex Assault Bellwether Lawsuits (07/15/2025)Uber Driver Background Check Materials Must Be Produced in Sexual Assault Lawsuits: Court (06/17/2025)MDL Judge Updated on Uber Driver Sex Assault Lawsuit Status as Claims Top 2,800 (06/06/2025)